Trametinib With GSK2141795 in BRAF Wild-type Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01941927

Recruitment Status : Unknown

Verified February 2015 by Adil Daud, University of California, San Francisco.
Recruitment status was: Active, not recruiting

First Posted : September 13, 2013

Last Update Posted : February 19, 2015

Sponsor:

Collaborator:

National Comprehensive Cancer Network

Information provided by (Responsible Party):

Adil Daud, University of California, San Francisco

Results Submitted - Not Posted on ClinicalTrials.gov

Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.

Recruitment Status :	Unknown
Actual Primary Completion Date :	December 2014
Estimated Study Completion Date :	May 2016

Submission Cycle	Results Submitted to ClinicalTrials.gov	Results Returned after Quality Control Review
1	February 28, 2018	March 27, 2018
2	May 4, 2018	June 6, 2018
3	June 8, 2018	June 11, 2018

To Top